Trial: 201905108

A Phase 1, First-In-Human, Open-label, Dose Escalation and Expansion Study of CUE-101 Monotherapy In Patients with HPV+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase

I

Principal Investigator

Adkins, Douglas

Disease Site

Ill-Defined Sites; Lip, Oral Cavity and Pharynx

Learn more about this study at: clinicaltrials.gov